eisai co ltd (4523:Tokyo Stock Exchange)
Chief Executive Officer, Representative Corporate Officer and Director,Eisai Co., Ltd.
|Age||Total Calculated Compensation||This person is connected to 12 board members in 1 different organizations across 4 different industries.|
See Board Relationships
As of Fiscal Year 2016
Mr. Haruo Naito has been the Chief Executive Officer of Eisai Co., Ltd. at Eisai, Inc. since June 2003 and has been its Representative Corporate Officer since June 2004. Mr. Naito has been President of Genox Research, Inc. since March 1996 and Drug Delivery System Institute, Ltd. since June 2003. He joined Eisai Co. Ltd. in October 1975 and became its Managing Director in June 1985; Representative Director and Senior Managing Director in June 1986; and Deputy President ...
4-6-10, KoishikawaPhone: 81 3 3817 3016
Tokyo, -- 112-8088
Fax: 81 3 3811 6032
Board Members Memberships*
Chief Executive Officer, Representative Corporate Officer and Director
Education*There is no Education data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Michael W. Aguiar||Chief Executive Officer, President, Director and Member of Stock Option Committee|
|Howard W. Robin||Chief Executive Officer, President and Director|
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|Peter S. Greenleaf||Chairman and Chief Executive Officer|
Sucampo Pharmaceuticals, Inc.
|Eduardo Javier Sanchiz Yrazu||Chief Executive Officer, Member of Management Board, Executive Director and Member of Compliance Committee|
|€1.2M||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.